Lupus Landmark Study: A Prospective Registry and Biorepository
Recruiting now NCT05934149
Run by Lupus Research Alliance · for 18 to 110 · All sexes
What this study is about
The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).
Who can join (things the study team will check)
✅ You may be able to join if…
- Able to understand and comply with study procedures and voluntarily sign a written informed consent document
- Age 18 years or older at the time of enrollment
- Fulfill criteria for SLE based on one or more of the following classifications systems: Systemic Lupus Erythematosus International Collaborating Clinic (SLICC) 2012 criteria; European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) 2019 criteria; 1997 revised ACR criteria; or Lupus is present per clinical assessment.
🚫 You may not be able to join if…
- Not able to obtain consent
- Not able to meet protocol visit requirements
- Pregnant at the time of enrollment
Where this trial is running
- University of Alabama at Birmingham, Birmingham, Alabama, United States
- University of Arizona, Tucson, Arizona, United States
- Wallace Rheumatic Studies Center, Beverly Hills, California, United States
- UCLA, Los Angeles, California, United States
- Georgetown University, Washington D.C., District of Columbia, United States
- University of Miami, Miami, Florida, United States
- Emory University, Atlanta, Georgia, United States
- University of Chicago, Chicago, Illinois, United States
- Brigham and Women's Hospital, Boston, Massachusetts, United States
- University of Massachusetts Memorial Health, Worcester, Massachusetts, United States
- Washington University, St Louis, Missouri, United States
- The Feinstein Institutes for Medical Research, Manhasset, New York, United States
+ 13 more sites.
Who to contact
Lupus Nexus Director · 646-884-6084 · lupusnexus@lupusresearch.org
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT05934149.
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.
Beacon is an information tool, not medical advice. Whether a trial is right for you is a decision for you, your doctor, and the study team. Trial details come from the official registry, ClinicalTrials.gov, and may change — always confirm with the study team. Beacon collects no data about you: this page has no cookies, no accounts, and no tracking.